Earnings call transcript: Macy’s beats Q2 2026 forecasts but shares fall premarket
Source: Investing.com

Macy’s reported Q2 adjusted EPS of $0.63, an 80% beat versus the $0.35 consensus estimate, while revenue rose 1.2% to $4.9B, exceeding forecasts by about 2.5%. Comparable sales increased 2.7%, gross margin expanded 180bps to 41.5%, and adjusted EBITDA climbed to $457M from $373M, supported partly by a $0.23-per-share tariff-refund benefit. Macy’s raised full-year EPS guidance to $2.15-$2.35 from $2.00-$2.10, but guided to a Q3 adjusted loss of $0.19-$0.23 per share and flat-to-down comparable sales; shares fell 3.95% premarket as investors questioned earnings durability and the retail outlook.
Analysis
The key debate is not whether M can produce another beat, but whether its higher-ticket assortment can sustain demand while conversion weakens. Premium mix raises sales per transaction and supports SG&A leverage, yet it also makes results more exposed to discretionary big-ticket categories and a consumer pullback; the weak Q3 setup creates a likely near-term de-rating window despite improved full-year optics. The reported margin step-up is not a clean run-rate signal: underlying merchandise-margin improvement appears modest once temporary items and reinvestment are removed.
Bloomingdale's and Bluemercury are becoming disproportionately important to the equity narrative because they offer faster growth, better customer demographics and more defensible vendor differentiation than the core Macy's banner. That should incrementally benefit premium suppliers such as RL and BOSS through expanded distribution and stronger full-price sell-through, although it also highlights the structural issue: the lower-growth core fleet still determines the consolidated multiple. Store-program outperformance is encouraging but lacks disclosed cohort-level ROI, leaving investors unable to distinguish sustainable productivity gains from investment-supported sales.
Near term, the premarket decline is rational rather than necessarily bearish: guidance implies a sharp profit trough before holiday benefits materialize. Over 1-3 months, flat-to-negative comparable sales, a promotional holiday market, or softer credit-card trends would challenge the turnaround narrative. Over 6-18 months, proof that the store format can scale with stable conversion and expanding gross margin could justify a rerating from a cash-flow/value multiple toward specialty-retail peers; failure would leave M as a low-multiple, capital-return story with limited growth credibility.
Contrarian view: consensus may be underestimating the value of redirecting temporary cash into customer acquisition and store productivity rather than maximizing current EPS, but management must demonstrate measurable payback by 2027. The cleaner signal is holiday gross-margin performance excluding nonrecurring benefits, not the current-quarter EPS beat.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
Key Decisions for Investors
- Maintain a tactical long M only on weakness below $20, sized modestly, with a 3-6 month horizon into holiday execution; target $24-25 if holiday comps remain positive and EBITDA margin holds near the implied full-year range. Exit if Q3 comparable sales fall below the guided range or if holiday gross-margin guidance is reduced.
- Express the quality split with long RL / short M over the next 6-12 months. RL has cleaner premium-brand exposure and less reliance on store-turnaround execution; use a 10-15% adverse relative-performance stop, particularly if broad discretionary demand accelerates and lifts department-store beta.
- Do not underwrite a structural M rerating until management discloses mature-store economics for Reimagine cohorts: sales lift net of labor, marketing, inventory and capex. Set an alert for Q4 results; evidence of conversion stabilization plus underlying gross-margin expansion would justify increasing the long.
- Avoid treating the temporary benefit as recurring earnings in valuation work. Use the Q3 loss and holiday inventory clearance as the stress test: a promotional spike or inventory growth materially above sales would favor a short M versus XRT rather than adding exposure.
More News
- Stocks Waver Ahead of PPI, Earnings, Brent Hits $102, Trump Vows Midterm Payout to Voters
- Jim Cramer's top 10 things to watch in the stock market Thursday
- What Wall Street thought of Apple's foldable iPhone and what the Duo means for the stock
- Chinese car exports are increasingly flooding the world despite all of the west’s (mixed) efforts to keep them out
- Macy's posts strong results, raises guidance as turnaround begins to take hold
- Roper Technologies at Citi’s 2026 Global TMT Conference: ai and m&a